Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year
Date:2/24/2011

2,119(Loss) earnings before income taxes and noncontrolling interest

(2,043)(25,889)355,944226,975Income tax (benefit) provision

(22,843)(73,312)10,402(20,773)Net earnings

20,80047,423345,542247,748Net (earnings) loss attributable to the noncontrolling interest

(952)(8,519)(427)(15,177)Net earnings attributable to Mylan Inc. before preferred dividends

19,84838,904345,115232,571Preferred dividends

17,25934,759121,535139,035Net earnings attributable to Mylan Inc. common shareholders

$
2,589$
4,145$
223,580$
93,536Earnings per common share attributable to Mylan Inc.common shareholders(1):Basic

$
.01$
.01$
.69$
.31Diluted

$
.01$
.01$
.68$
.30Weighted average common shares outstanding(1):Basic

372,401305,797324,453305,162Diluted

376,876309,396328,979306,913(1)  The three and twelve months ended December 31, 2010 include the effect of the Preferred Stock Conversion into approximately 125.2 million shares of Mylan common stock on November 15, 2010.Mylan Inc. and SubsidiariesCondensed Consolidated Balance Sheets(Unaudited; in thousands)December 31, 2010December 31, 2009Assets:   Current assets:Cash and cash equivalents

$
2,052$
380,516Restricted cash

23,97247,965Marketable securities

29,08527,559Accounts receivable, net

1,157,0811,234,634Inventories

1,240,2711,114,219Other current assets

446,982480,493Total current assets

3,559,4433,285,386   Intangible assets, net

2,501,1502,384,848   Goodwill

3,599,3343,331,247   Other non-current assets

1,876,8771,800,253Total assets

$
,536,804$
,801,734Liabilities:   Current liabilities

$
,809,612$
,718,147   Long-term debt

5,263,3764,984,987   Other non-current liabilities

848,415953,402Total liabilities

7,921,4037,656,536Noncontrolling interest

13,52214,05
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
2. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
3. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
4. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
5. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
6. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
7. Mylan Confirms Four First-to-File Challenges
8. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
9. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
10. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
11. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Vernon Hills, Ill. (PRWEB) May 16, 2013 ... including benchtop and portable models, from Cole-Parmer is ... professionals. The enhanced line includes: , The new ... that are true workhorses in the lab. They ... superior serum and plasma specimen separation. Their standard ...
(Date:5/16/2013)... May 16, 2013  The registration deadline has been ... Officers (ABFO) 2013 National Conference, the premier conference for ... 28-31 at the Hilton San Diego Bayfront. ... year,s conference and want to make sure as many ... Brandi Roberts , Chief Financial Officer ...
(Date:5/16/2013)... YORK , May 16, 2013 ... new market research report is available ... Competitor Analysis: Therapeutic ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The new ...
(Date:5/16/2013)... Dr. Stephen Y. Chou, Founder of Nanonex ... and Applications” at IEEE Nano 2013 in Beijing, China, ... by Chou, is becoming one of the most critical ... sub-10 nm resolution, large area, and low cost unmatchable ... and manufacturing in a broad range of industries, from ...
Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... , STOCKHOLM, ... European Investment Fund (EIF) has entered into a,co-investment agreement ... Karolinska Development and used to invest in the company,s,portfolio ... to invest 26.7 M Euros in the co-investment fund. ...
... Most people would like to be able to charge ... not too often. A recent discovery made by UC ... that could do just this. In recent ... Bandaru, a professor in the UCSD Department of Mechanical ...
... , BETHESDA, Md., Nov. 19 ... for diabetes therapy, and a provider of technical and regulatory ... today it closed the previously reported $6.3 million registered direct ... stock and warrants to purchase up to 1,104,348 additional shares ...
Cached Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
(Date:5/18/2013)... 2013) The AGA Research Foundation is honored to ... Award in Digestive Cancer, which will support Andrew D. ... the University of Pennsylvania, Philadelphia, as he furthers his ... regeneration and cancer progression. , "The AGA Research Foundation ... two distinguished clinicians and AGA Legacy Society members," said ...
(Date:5/18/2013)... 2013) Research presented today at Digestive Disease Week ... findings about the impact of coffee on autoimmune disease ... coffee consumption recently has been associated with reduced risk ... few more cups of java each month also correlate ... Researchers at the Mayo Clinic, Rochester, MN, linked coffee ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) Research presented ... for managing digestive health through diet and lifestyle. ... often plagued by reduced muscle strength, fatigue and ... even when patients are in remission. A randomized, ... time that vitamin D supplementation corresponded to significant ...
Breaking Biology News(10 mins):AGA Research Foundation grant furthers digestive cancer research 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3
... A groundbreaking study lead by Chapman University professor Brennan ... will be published in the May 5th edition ... reproductive biology. It is the first such study ... the USA, the postponement of childbearing is reflective of ...
... The American Academy of OtolaryngologyHead and Neck Surgery (AAO-HNS) ... physicians. Clinical indicators for otolaryngology serve as a checklist ... clinical departments. The Clinical Indicators are created by the ... define a basis of medical necessity for a range ...
... LSU,s Mark Batzer, along with research associate Jerilyn Walker and ... orangutans are host to ancient jumping genes called Alu, which ... done in collaboration with the Zoological Society of San Diego ... featured in the new open access journal Mobile DNA ...
Cached Biology News:New study published on fertility awareness among American university students 2LSU research finds orangutans host ancient jumping genes 2
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....
Human CXCL14/BRAK Affinity Purified Polyclonal Ab...
Biology Products: